To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

NCT05296044 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: JT-003
DRUG: JT-003 Placebo

Sponsor

Jeil Pharmaceutical Co., Ltd.